Olmesartan medoxomil ameliorates sciatic nerve regeneration in diabetic rats

NeuroReport

Volumn 20, Issue 16, 2009, Pages 1481-1485

  Nakamura, Hiroaki ^a   Domon, Yuki ^a   Inoue, Tatsuya ^a   Arakawa, Naohisa ^a   Yokoyama, Tomihisa ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

Angiotensin II type1 receptor blocker; Ciliary neurotrophic factor; Diabetic neuropathy; Dorsal root ganglia; Insulin like growth factor; Nerve growth factor; Nerve regeneration; Neurotrophin 3; Olmesartan medoxomil; Streptozotocin

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CILIARY NEUROTROPHIC FACTOR; MESSENGER RNA; OLMESARTAN; SOMATOMEDIN C; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CILIARY NEUROTROPHIC FACTOR RECEPTOR; DRUG DERIVATIVE; IMIDAZOLE DERIVATIVE; INSULIN LIKE GROWTH FACTOR I, VAL(59); INSULIN-LIKE GROWTH FACTOR I, VAL(59)-; NEUROTROPHIN 3; STREPTOZOCIN; TETRAZOLE DERIVATIVE;

ARTICLE; DIABETIC NEUROPATHY; DRUG DOSE REDUCTION; NERVE COMPRESSION; NERVE CRUSH; NERVE REGENERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCIATIC NERVE; SPINAL GANGLION; STREPTOZOCIN DIABETES; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENETICS; HEMISPHERIC DOMINANCE; MALE; METABOLISM; PATHOPHYSIOLOGY; RAT; SCIATIC NEUROPATHY; SPRAGUE DAWLEY RAT;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; CILIARY NEUROTROPHIC FACTOR; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FUNCTIONAL LATERALITY; GANGLIA, SPINAL; GENE EXPRESSION REGULATION; IMIDAZOLES; INSULIN-LIKE GROWTH FACTOR I; MALE; NERVE REGENERATION; NEUROTROPHIN 3; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CILIARY NEUROTROPHIC FACTOR; RNA, MESSENGER; SCIATIC NEUROPATHY; STREPTOZOCIN; TETRAZOLES;

EID: 74049133332     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e32833283e6     Document Type: Article

References (21)

1. Veves A, Akbari CM, Primavera J, Donaghue VM, Zacharoulis D, Chrzan JS, et al. Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes 1998; 47:457-463.
2. Dyck PJ, Giannini C. Pathologic alterations in the diabetic neuropathies of humans: a review. J Neuropathol Exp Neurol 1996; 55:1181-1193.
3. Bradley JL, Thomas PK, King RH, Muddle JR, Ward JD, Tesfaye S, et al. Myelinated nerve fibre regeneration in diabetic sensory polyneuropathy: correlation with type of diabetes. Acta Neuropathol 1995; 90:403-410.
4. Cameron NE, Cotter MA, Robertson S. Angiotensin converting enzyme inhibition prevents development of muscle and nerve dysfunction and stimulates angiogenesis in streptozotocin-diabetic rats. Diabetologia 1992; 35:12-18.
5. Maxfield EK, Cameron NE, Cotter MA, Dines KC. Angiotensin II receptor blockade improves nerve function, modulates nerve blood flow and stimulates endoneurial angiogenesis in streptozotocin-diabetic rats and nerve function. Diabetologia 1993; 36:1230-1237.
6. Coppey LJ, Davidson EP, Rinehart TW, Gellett JS, Oltman CL, Lund DD, et al. ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats. Diabetes 2006; 55:341-348.
7. Malik RA, Williamson S, Abbott C, Carrington AL, Iqbal J, Schady W, et al. Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial. Lancet 1998; 352:1978-1981.
8. Reja A, Tesfaye S, Harris ND, Ward JD. Is ACE inhibition with lisinopril helpful in diabetic neuropathy? Diabet Med 1995; 12:307-309.
9. Maxfield EK, Love A, Cotter MA, Cameron NE. Nerve function and regeneration in diabetic rats: effects of ZD-7155, an AT1 receptor antagonist. Am J Physiol 1995; 269:E530-E537.
10. Reinecke K, Lucius R, Reinecke A, Rickert U, Herdegen T, Unger T. Angiotensin II accelerates functional recovery in the rat sciatic nerve in vivo: role of the AT2 receptor and the transcription factor NF-kappaB. FASEB J 2003; 17:2094-2096.
11. Mizuno M, Sada T, Kato M, Koike H. Renoprotective effects of blockade of angiotensin II AT1 receptors in an animal model of type 2 diabetes. Hypertens Res 2002; 25:271-278.
12. Nakamura H, Inoue T, Arakawa N, Shimizu Y, Yoshigae Y, Fujimori I, et al. Pharmacological and pharmacokinetic study of olmesartan medoxomil in animal diabetic retinopathy models. Eur J Pharmacol 2005; 512:239-246.
13. Iwasaki Y, Ichikawa Y, Igarashi O, Kinoshita M, Ikeda K. Trophic effect of olmesartan, a novel AT1R antagonist, on spinal motor neurons in vitro and in vivo. Neurol Res 2002; 24:468-472.
14. Terenghi G. Peripheral nerve regeneration and neurotrophic factors. J Anat 1999; 194:1-14.
15. Lee SE, Shen H, Taglialatela G, Chung JM, Chung K. Expression of nerve growth factor in the dorsal root ganglion after peripheral nerve injury. Brain Res 1998; 796:99-106.
16. Craner MJ, Klein JP, Black JA,Waxman SG. Preferential expression of IGF-I in small DRG neurons and down-regulation following injury. Neuroreport 2002; 13:1649-1652.
17. Sango K, Horie H, Saito H, Ajiki K, Tokashiki A, Takeshita K, et al. Diabetes is not a potent inducer of neuronal cell death in mouse sensory ganglia, but it enhances neurite regeneration in vitro. Life Sci 2002; 71: 2351-2368.
18. Sendtner M, Gotz R, Holtmann B, Escary JL, Masu Y, Carroll P, et al. Cryptic physiological trophic support of motoneurons by LIF revealed by double gene targeting of CNTF and LIF. Curr Biol 1996; 6:686-694.
19. Mizisin AP, Vu Y, Shuff M, Calcutt NA. Ciliary neurotrophic factor improves nerve conduction and ameliorates regeneration deficits in diabetic rats. Diabetes 2004; 53:1807-1812.
20. Sango K, Yanagisawa H, Takaku S. Expression and histochemical localization of ciliary neurotrophic factor in cultured adult rat dorsal root ganglion neurons. Histochem Cell Biol 2007; 128:35-43.
21. Bleuel A, de Gasparo M, Whitebread S, Puttner I, Monard D. Regulation of protease nexin-1 expression in cultured Schwann cells is mediated by angiotensin II receptors. J Neurosci 1995; 15:750-761.